Danone launches improved $307m bid for Lifeway
The revised offer represents ‘compelling value’ to Lifeway’s shareholders according to Danone’s Shane Grant and comes after the kefir maker’s Board rejected the dairy major’s $283m proposal.
The revised offer represents ‘compelling value’ to Lifeway’s shareholders according to Danone’s Shane Grant and comes after the kefir maker’s Board rejected the dairy major’s $283m proposal.
The supplementation of a whey-derived peptide has been shown to lower self-perceived levels of stress among middle-aged adults, according to a six-week study conducted by Kirin Holdings.